Literature DB >> 6135473

alpha 1-Adrenoceptor agonist activity of alpha 2-adrenoceptor antagonists in the pithed rat preparation.

P M Paciorek, N B Shepperson.   

Abstract

The selective alpha 2-adrenoceptor antagonist, RX781094, evoked a dose-related pressor response in the pithed rat preparation when administered in bolus doses by the intravenous route. This response was enhanced following depletion of endogenous amines by reserpine, and inhibited by the selective alpha 1-adrenoceptor antagonist, prazosin. Two other selective alpha 2-adrenoceptor antagonists, Wy26703 and Wy26392, had no marked effect on the blood pressure of this preparation. Pretreatment of the preparation with Wy26703 had no significant effect on the pressor response evoked by RX781094. It is concluded that RX781094 is an alpha 1-adrenoceptor agonist at similar doses to those at which it exhibits alpha 2-adrenoceptor antagonist properties. The agonist activity exhibited by RX781094 is not a general property of all alpha 2-adrenoceptor antagonists and should be considered when this compound is employed as an alpha 2-adrenoceptor antagonist.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135473      PMCID: PMC2044847          DOI: 10.1111/j.1476-5381.1983.tb10488.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  3 in total

1.  Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

Authors:  D Cambridge; M J Davey; R Massingham
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

2.  Pre- and postsynaptic alpha-adrenoceptor antagonism by indoramin in isolated tissues of the rat.

Authors:  K F Rhodes; J F Waterfall
Journal:  J Pharm Pharmacol       Date:  1978-08       Impact factor: 3.765

Review 3.  Presynaptic regulation of catecholamine release.

Authors:  S Z Langer
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

  3 in total
  14 in total

1.  Analysis of the action of idazoxan calls into question the reliability of the rat isolated small mesenteric artery assay as a predictor for alpha 1-adrenoceptor-mediated pressor activity.

Authors:  P H Van der Graaf; N P Shankley; J W Black
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

2.  Effect of removing the endothelial cells on the reactivity of rat aortic segments to different alpha-adrenoceptor agonists.

Authors:  I Lues; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

3.  Exploring the pharmacology of the pro-convulsant effects of alpha 2-adrenoceptor antagonists in mice.

Authors:  H C Jackson; S L Dickinson; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.

Authors:  J F Hussain; D A Kendall; V G Wilson
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

5.  Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine.

Authors:  D R Allan; S B Penner; D D Smyth
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

6.  Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.

Authors:  J C Doxey; A C Lane; A G Roach; N K Virdee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

7.  Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.

Authors:  R G Evans; W P Anderson
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Difference in the potency of alpha 2-adrenoceptor agonists and antagonists between the pithed rabbit and rat.

Authors:  J M Bulloch; J R Docherty; N A Flavahan; J C McGrath; C E McKean
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

9.  Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.

Authors:  J C Doxey; A G Roach; D A Strachan; N K Virdee
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

10.  Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743.

Authors:  D J Pettibone; B V Clineschmidt; V J Lotti; J J Baldwin; J R Huff; W C Randall; J Vacca; S D Young
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.